2025-01-24 10:50:00 :
Syngene International’s third quarter of 2025 performance: Syngene International announced the third quarter performance on January 23, 2025, reporting its financial situation significantly. The company’s revenue increased by 10.57%year -on -year, and the profit increased significantly year -on -year to 17.58%to reach $1.311 billion rupees. Income $9.437 billion rupees marked a strong performance in the field of competitive biopharmaceuticals.
Compared with the previous quarter, Syngene International showed a steady growth, with income increased by 5.91%and profit increased by 23.56%. The company’s effective management costs, sales, general and management costs decreased by 0.8%month -on -month, but increased by 12.95%year -on -year.
Operating income increased significantly, an increase of 33.64%month -on -month, a year -on -year increase of 31.11%, and operating efficiency was strong. In the third quarter of the earnings per share (EPS) report $3.26, an increase of 14.79%year -on -year.
The return rate of Syngene International was 3.68%last week, and the return rate in the past six months was 7.65%. Although the return rate of (YTD) so far this year is -1.33%.
As of January 24, 2025, the market value $33,995.03 million Rs Rice, a 52 -week new high $960.6 and minimum $607.65. The performance of the stock has attracted the attention of analysts. Three of the analysts gave selling rating, 1 analyst given a rating, 3 analysts gave buying rating, and one analyst also gave a strong buy rating rating rating. Essence
As of January 24, 2025, the consensus proposal is still holding, reflecting the cautious prospects in the competition pattern.
Syngene International Finance
| period | In the third quarter (fiscal year 2025) | In the second quarter (25 fiscal year) | Growing up | In the third quarter (fiscal year 2024) | Year -on -year increase |
|---|---|---|---|---|---|
| Total income | 943.7 | Chapter 891 | +5.91% | 853.5 | +10.57% |
| Sales/general/management costs total | 249.5 | 251.5 | -0.8% | 220.9 | +12.95% |
| Depreciation/amortization | 108.7 | 110.9 | -1.98% | 108.1 | +0.56% |
| Total business expenses | 770.5 | 761.4 | +1.2% | 721.4 | +6.81% |
| Operating income | 173.2 | 129.6 | +33.64% | 132.1 | +31.11% |
| Net income pre -tax income | 180.8 | 137.3 | +31.68% | 138.2 | +30.82% |
| net income | 131.1 | 106.1 | +23.56% | 111.5 | +17.58% |
| Dilute standardization per share earnings per share | 3.26 | 2.64 | +23.48% | 2.84 | +14.79% |
Disclaimer: This is a real -time blog generated by artificial intelligence.Essence
Follow us On Social Media Twitter/X